Patient Selection for Surgical Management of Primary and Metastatic Liver Cancers: Current Perspectives

ABSTRACT

The surgical management of liver malignancies remains a mainstay in the treatment of such patients, and has benefited from dramatic advancements over the last two decades. Improvements in surgical technique, better understanding of hepatic anatomy, and improvement in anesthesiological supportive care has resulted in a decline in perioperative morbidity and operative mortality. Proper patient selection for surgical and nonsurgical treatment currently employs a multidisciplinary approach in our institution. This review will focus on the surgical treatment options for both primary and secondary liver cancers.

Liver cancer - surgery - ablative therapy

REFERENCES

• 1 Poon R T, Fan S T, Lo C M et al.. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years.  Ann Surg. 2001;  234 63-70
• 2 Gibbs J F, Litwin A, Kahlenberg M S. Contemporary management of benign liver tumors.  Surg Clin North Am. 2004;  84 463-480
• 3 Shoup M, Gonen M, D'Angelica M et al.. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection.  J Gastrointest Surg. 2003;  7 325-330
• 4 Blumgart L H, Leach K G, Karran S J. Observations on liver regeneration after right hepatic lobectomy.  Gut. 1971;  12 922-928
• 5 Lee K C, Kinoshita H, Hirohashi K, Kubo S, Iwasa R. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization.  World J Surg. 1993;  17 109-115
• 6 Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma.  World J Surg. 1986;  10 803-808
• 7 Wakabayashi H, Ishimura K, Okano K et al.. Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma.  Surgery. 2002;  131 26-33
• 8 Farges O, Belghiti J, Kianmanesh R et al.. Portal vein embolization before right hepatectomy: prospective clinical trial.  Ann Surg. 2003;  237 208-217
• 9 Azoulay D, Castaing D, Krissat J et al.. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver.  Ann Surg. 2000;  232 665-672
• 10 Elias D, De Baere T, Roche A, Ducreux M, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma.  Br J Surg. 1999;  86 784-788
• 11 Wakabayashi H, Ishimura K, Okano K et al.. Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma?.  Cancer. 2001;  92 2384-2390
• 12 Gibbs J F, Weber T K, Rodriguez-Bigas M A, Driscoll D L, Petrelli N J. Intraoperative determinants of unresectability for patients with colorectal hepatic metastases.  Cancer. 1998;  82 1244-1249
• 13 Kane J M, Kahlenberg M S, Kanter P M et al.. Intraoperative hepatic lymphatic mapping in patients with colorectal liver metastases.  Am Surg. 2002;  68 745-750
• 14 Staren E D, Gambla M, Deziel D J et al.. Intraoperative ultrasound in the management of liver neoplasms.  Am Surg. 1997;  63 591-596 , discussion 596-597
• 15 Jarnagin W R, Bach A M, Winston C B et al.. What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease?.  J Am Coll Surg. 2001;  192 577-583
• 16 Antonetti M C, Killelea B, Orlando III R. Hand-assisted laparoscopic liver surgery.  Arch Surg. 2002;  137 407-411 , discussion 412
• 17 Dulucq J L, Wintringer P, Stabilini C, Berticelli J, Mahajna A. Laparoscopic liver resections: a single center experience.  Surg Endosc. 2005;  19 886-891
• 18 Gigot J F, Glineur D, Santiago Azagra J et al.. Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study.  Ann Surg. 2002;  236 90-97
• 19 Fong Y, Jarnagin W, Conlon K C, DeMatteo R, Dougherty E, Blumgart L H. Hand-assisted laparoscopic liver resection: lessons from an initial experience.  Arch Surg. 2000;  135 854-859
• 20 Marks J, Mouiel J, Katkhouda N, Gugenheim J, Fabiani P. Laparoscopic liver surgery: a report on 28 patients.  Surg Endosc. 1998;  12 331-334
• 21 Parkin D M, Pisani P, Ferlay J. Global cancer statistics.  CA Cancer J Clin. 1999;  49 33-64
• 22 Ebara M, Hatano R, Fukuda H, Yoshikawa M, Sugiura N, Saisho H. Natural course of small hepatocellular carcinoma with underlying cirrhosis: a study of 30 patients.  Hepatogastroenterology. 1998;  45(suppl 3) 1214-1220
• 23 Fong Y, Sun R L, Jarnagin W, Blumgart L H. An analysis of 412 cases of hepatocellular carcinoma at a Western center.  Ann Surg. 1999;  229 790-799 , discussion 799-800
• 24 Llovet J M, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.  Hepatology. 1999;  30 1434-1440
• 25 Margarit C, Hidalgo E, Charco R et al.. [Improvement in the results of surgical resection of hepatocellular carcinoma].  Gastroenterol Hepatol. 2001;  24 465-472
• 26 Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000.  Surgery. 2002;  131(suppl) S153-S158
• 27 Grazi G L, Cescon M, Ravaioli M et al.. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics: evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre.  Aliment Pharmacol Ther. 2003;  17(suppl 2) 119-129
• 28 Ercolani G, Grazi G L, Ravaioli M et al.. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.  Ann Surg. 2003;  237 536-543
• 29 Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.  Ann Surg. 2003;  238 703-710
• 30 Bismuth H. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management.  Am J Gastroenterol. 1999;  94 2336-2337
• 31 Lui W Y, Chau G Y, Wu C W, King K L. Surgical resection of hepatocellular carcinoma in elderly cirrhotic patients.  Hepatogastroenterology. 1999;  46 640-645
• 32 Makino Y, Yamanoi A, Kimoto T, El-Assal O N, Kohno H, Nagasue N. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.  Am J Gastroenterol. 2000;  95 1294-1300
• 33 Haug C E, Jenkins R L, Rohrer R J et al.. Liver transplantation for primary hepatic cancer.  Transplantation. 1992;  53 376-382
• 34 McCormack L, Petrowsky H, Clavien P A. Surgical therapy of hepatocellular carcinoma.  Eur J Gastroenterol Hepatol. 2005;  17 497-503
• 35 Lau W Y, Leung T W, Ho S K et al.. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.  Lancet. 1999;  353 797-801
• 36 Li J Q, Zhang Y Q, Zhang W Z, Yuan Y F, Li G H. Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy.  J Cancer Res Clin Oncol. 1995;  121 364-366
• 37 Majno P E, Adam R, Bismuth H et al.. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.  Ann Surg. 1997;  226 688-701 , discussion 701-703
• 38 Llovet J M, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma.  Semin Liver Dis. 2005;  25 181-200
• 39 Paye F, Jagot P, Vilgrain V, Farges O, Borie D, Belghiti J. Preoperative chemoembolization of hepatocellular carcinoma: a comparative study.  Arch Surg. 1998;  133 767-772
• 40 Wu C C, Ho Y Z, Ho W L, Wu T C, Liu T J, P'Eng F K. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal.  Br J Surg. 1995;  82 122-126
• 41 Yamasaki S, Hasegawa H, Kinoshita H et al.. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma.  Jpn J Cancer Res. 1996;  87 206-211
• 42 Fong Y. Surgical therapy of hepatic colorectal metastasis.  CA Cancer J Clin. 1999;  49 231-255
• 43 Kooby D A, Jarnagin W R. Surgical management of hepatic malignancy.  Cancer Invest. 2004;  22 283-303
• 44 Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. II: the prognosis for patients with hepatic metastases from gastric carcinoma verified by laparotomy and postmortem examination.  Digestion. 1969;  2 179-186
• 45 Wood C B, Gillis C R, Blumgart L H. A retrospective study of the natural history of patients with liver metastases from colorectal cancer.  Clin Oncol. 1976;  2 285-288
• 46 Willett C G, Tepper J E, Cohen A M, Orlow E, Welch C E. Failure patterns following curative resection of colonic carcinoma.  Ann Surg. 1984;  200 685-690
• 47 Saltz L B, Cox J V, Blanke C et al.. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.  N Engl J Med. 2000;  343 905-914
• 48 Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases.  World J Surg. 1995;  19 59-71
• 49 Fong Y, Fortner J, Sun R L, Brennan M F, Blumgart L H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.  Ann Surg. 1999;  230 309-318 , discussion 318-321
• 50 Nordlinger B, Guiguet M, Vaillant J C et al.. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie.  Cancer. 1996;  77 1254-1262
• 51 Fong Y, Cohen A M, Fortner J G et al.. Liver resection for colorectal metastases.  J Clin Oncol. 1997;  15 938-946
• 52 Jamison R L, Donohue J H, Nagorney D M, Rosen C B, Harmsen W S, Ilstrup D M. Hepatic resection for metastatic colorectal cancer results in cure for some patients.  Arch Surg. 1997;  132 505-510 , discussion 511
• 53 Choti M A, Sitzmann J V, Tiburi M F et al.. Trends in long-term survival following liver resection for hepatic colorectal metastases.  Ann Surg. 2002;  235 759-766
• 54 Adson M A, van Heerden J A, Adson M H, Wagner J S, Ilstrup D M. Resection of hepatic metastases from colorectal cancer.  Arch Surg. 1984;  119 647-651
• 55 Khushalani N I, McKinley B P, Gibbs J F, Leichman C G, Petrelli N J. Regional chemotherapy is indicated after surgical resection of colorectal metastases to the liver: a debate.  J Surg Oncol. 2003;  82 65-72
• 56 Kemeny N, Gonen M, Sullivan D et al.. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer.  J Clin Oncol. 2001;  19 2687-2695
• 57 Chamberlain R S, Canes D, Brown K T et al.. Hepatic neuroendocrine metastases: does intervention alter outcomes?.  J Am Coll Surg. 2000;  190 432-445
• 58 Que F G, Nagorney D M, Batts K P, Linz L J, Kvols L K. Hepatic resection for metastatic neuroendocrine carcinomas.  Am J Surg. 1995;  169 36-42 , discussion 42-43
• 59 Dousset B, Saint-Marc O, Pitre J, Soubrane O, Houssin D, Chapuis Y. Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation.  World J Surg. 1996;  20 908-914
• 60 Chen H, Hardacre J M, Uzar A, Cameron J L, Choti M A. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?.  J Am Coll Surg. 1998;  187 88-92
• 61 Elias D, Cavalcanti de Albuquerque A, Eggenspieler P et al.. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients.  J Am Coll Surg. 1998;  187 487-493
• 62 DeMatteo R P, Shah A, Fong Y, Jarnagin W R, Blumgart L H, Brennan M F. Results of hepatic resection for sarcoma metastatic to liver.  Ann Surg. 2001;  234 540-547 , discussion 547-548
• 63 Elias D, Lasser P H, Montrucolli D, Bonvallot S, Spielmann M. Hepatectomy for liver metastases from breast cancer.  Eur J Surg Oncol. 1995;  21 510-513
• 64 Gournay J, Tchuenbou J, Richou C et al.. Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis.  Aliment Pharmacol Ther. 2002;  16 1529-1538
• 65 Choti M A. Surgical management of hepatocellular carcinoma: resection and ablation.  J Vasc Interv Radiol. 2002;  13 S197-S203
• 66 Adam R, Hagopian E J, Linhares M et al.. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies.  Arch Surg. 2002;  137 1332-1339 , discussion 1340
• 67 Lencioni R A, Allgaier H P, Cioni D et al.. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.  Radiology. 2003;  228 235-240